Technical Data
| Formula | C17H23ClO4 |
||||||||||||||
| Molecular Weight | 326.82 | CAS No. | 124083-20-1 | ||||||||||||
| Solubility (25°C)* | In vitro | DMSO | 65 mg/mL (198.88 mM) | ||||||||||||
| Ethanol | 65 mg/mL (198.88 mM) | ||||||||||||||
| Water | Insoluble | ||||||||||||||
| In Vivo (Add solvents to the product individually and in order.) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
|||||||||||||||
Preparing Stock Solutions
Biological Activity
| Description | Etomoxir ((R)-(+)-Etomoxir) is an irreversible, small-molecule inhibitor of carnitine palmitoyl-transferase 1a (CPT1a). It inhibits fatty acid oxidation (FAO) and may have potential in treating diabetes, inflammation, cancer and cardiac metabolic diseases. | |
|---|---|---|
| Targets |
|
Protocol (from reference)
References
|
Sellecks Etomoxir Has Been Cited by 5 Publications
| Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation [ Mol Cancer, 2025, 24(1):34] | PubMed: 39876004 |
| Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer [ Cell Metab, 2025, 37(11):2233-2249.e9] | PubMed: 41138721 |
| Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusion [ J Clin Invest, 2025, 135(23)e182480] | PubMed: 41026528 |
| OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression [ Cell Rep, 2025, 44(7):115901] | PubMed: 40608514 |
| Vitamin A-treated natural killer cells reduce interferon-gamma production and support regulatory T-cell differentiation [ Eur J Immunol, 2024, 54(7):e2250342] | PubMed: 38593338 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.